Coverage
-
July 06, 2017
GlaxoSmithKline told a North Carolina federal judge Wednesday that it should be allowed to argue in its lawsuit accusing Abbott Laboratories of violating a license agreement by raising the price of an HIV drug that Abbott undervalued some GSK patents in a reciprocal deal.
1 other articles on this case.
View all »